Bronchoalveolar lavage fluid and serum complement activity in pulmonary sarcoidosis.
In this work, using bronchoalveolar lavage fluids (BALF), we demonstrated the presence of complement within airways by assaying hemolytic activity of the whole classical pathway (CH50) and by measuring the complement component C2 (C2H50). Patients with sarcoidosis, patients with idiopathic pulmonary fibrosis (IPF), and healthy control subjects were compared. No CH50 activity was found in BALF from healthy control subjects (n = 9), but some activity (mean, 20 CH50) was associated with IPF (n = 7). Complement activities ranged from 40 to 554 CH50 in patients with sarcoidosis (n = 27). During the treatment, complement activity decreased in BALF from the few patients in our series who received corticotherapy. C2 hemolytic activity was detected in BALF from the normal control group (in the absence of CH50 activity). In the sarcoidosis and IPF groups when CH50 was present, the variations in the C2/CH50 ratio were studied. The high ratio observed in BALF from patients with sarcoidosis and a chronic derangement of alveolar structure suggests either an increased C2 production or an alternative complement pathway (C2-independent) activation within their lungs.
D000328:Adult; D001826:Body Fluids / Q000032:analysis*; D003175:Complement C2 / Q000032:analysis; D003176:Complement C3 / Q000032:analysis; D003179:Complement C3b / Q000032:analysis; D003165:Complement System Proteins / Q000032:analysis*; D005260:Female; D006461:Hemolysis; D006801:Humans; D007122:Immunoelectrophoresis; D008171:Lung Diseases / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011650:Pulmonary Alveoli / Q000032:analysis*; D012507:Sarcoidosis / Q000378:metabolism*; D007507:Therapeutic Irrigation
D003175:Complement C2; D003176:Complement C3; D003179:Complement C3b; D003165:Complement System Proteins